Laryxin Menthol

Medicinal product

(Invented) name

Laryxin Menthol

Active substance (s)

Chlorheksidino digliukonatas/Lidokaino hidrochloridas monohidratas

Strength

2 mg/0,5 mg/ml

Pharmaceutical form

burnos gleivinės purškalas (tirpalas)

Route (s) of administration

vartoti ant burnos gleivinės

Legal status for supply

Nereceptinis

Narrow therapeutic index (NTI)

ATC code (s)

R02AA05, Chlorhexidine

Marketing authorisation holder

Orifarm Healthcare A/S, Danija

Date of authorisation

2024-06-27

Date of renewal

Documents

Stage

Registruotas

Controlled?

Controlled substance type

Legal basis

10a

Procedure number

NO/H/0349/002/MR

Marketing authorisation procedure

Savitarpio pripažinimo procedūra

Qualitative and quantitative composition

1 ml purškalo yra:	1 ml
Chlorheksidino digliukonatas	2 mg
Lidokaino hidrochloridas monohidratas	0,5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
113985	100101	1100101	buteliukas	30 ml N1		Nereceptinis	LT/1/24/5473/001	Tiekiama	2025-01-01	-	No	-	-	Download

Stadijos

Data	Stadija
2024-06-27	Registruotas